Work

Neoadjuvant chemoradiotherapy with or without PD-1 blockade in pMMR/MSS low rectal cancer patients (CHOICE II): A multi-center, open-label, randomized controlled trial.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3640

Authors: Wei Zhang, Guanyu Yu, Leqi Zhou, Hongwei Yao, Jianhua Ding, Wenbin Chen, Liqiang Hao, Jianbin Xiang, Dongwang Yan, Jinlin Du, Shugui Pan, Zhiqiang Zhu, Huojun Zhang, Chenguang Bai, Fu Shen, Yuxin Shen, Wei Wang, Xiaolan Yin, CHOICE II Study Group

Institutions: Changhai Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Chinese People's Liberation Army, First Affiliated Hospital Zhejiang University, Fudan University, Huashan Hospital, Shanghai Jiao Tong University, Shanghai First People's Hospital, Zhejiang University, University of Science and Technology of China, Second Military Medical University, Shanghai University

Language: English

Topic: Colorectal Cancer Surgical Treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

Award: G5833195049

OpenAlex ID: W7162487980

Cites:

Cited by:

Related to: